Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Madsbad

Showing results (31-40 of 223) with videos related to

Pageof 23
Sort By:
Ugeskrift for Laeger|May 31, 2001
[New discoveries about the cause of diabetes. Type 2 diabetes mellitus changed to "obesity-dependent diabetes mellitus"]A V Astrup, S Madsbad, N Finer
Thrombosis and Haemostasis|June 28, 1982
Changes in platelet function, blood coagulation and fibrinolysis during insulin-induced hypoglycaemia in juvenile diabetics and normal subjectsJ Dalsgaard-Nielsen, S Madsbad, J Hilsted
Expert Review of Clinical Pharmacology|November 18, 2015
Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a reviewL Østergaard, Christian S Frandsen, S Madsbad
Acta Endocrinologica|January 1, 1987
Heterogeneity of immunoreactive gastric inhibitory polypeptide in the plasma of newly diagnosed type 1 (insulin-dependent) diabeticsT Krarup, J J Holst, S Madsbad
The Journal of Clinical Investigation|March 1, 1983
Whole body clearance of norepinephrine. The significance of arterial sampling and of surgical stressJ Hilsted, N J Christensen, S Madsbad
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1987
Reproducibility of the glucagon testS Arnold-Larsen, S Madsbad, C Kühl
Diabetologia|December 11, 2008
The proposed terminology 'A1c-derived average glucose' is inherently imprecise and should not be adopted. Reply to Bloomgarden ZT, Inzucchi SE, Karnieli E, et alS B Haugaard, S Madsbad, J Mølvig
The Journal of Clinical Endocrinology and Metabolism|January 1, 1985
Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitusT Krarup, S Madsbad, A J Moody
Diabetologia|November 3, 2001
Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methodsL L Kjems, A Vølund, S Madsbad
Acta Chirurgica Scandinavica|February 1, 1986
Changes in T-lymphocyte subsets after elective surgeryS Madsbad, K Buschard, O Siemssen, et al.
Pageof 23

Showing results (31-40 of 223) with videos related to

Sort By:
Pageof 23
Ugeskrift for Laeger|May 31, 2001
[New discoveries about the cause of diabetes. Type 2 diabetes mellitus changed to "obesity-dependent diabetes mellitus"]A V Astrup, S Madsbad, N Finer
Thrombosis and Haemostasis|June 28, 1982
Changes in platelet function, blood coagulation and fibrinolysis during insulin-induced hypoglycaemia in juvenile diabetics and normal subjectsJ Dalsgaard-Nielsen, S Madsbad, J Hilsted
Expert Review of Clinical Pharmacology|November 18, 2015
Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a reviewL Østergaard, Christian S Frandsen, S Madsbad
Acta Endocrinologica|January 1, 1987
Heterogeneity of immunoreactive gastric inhibitory polypeptide in the plasma of newly diagnosed type 1 (insulin-dependent) diabeticsT Krarup, J J Holst, S Madsbad
The Journal of Clinical Investigation|March 1, 1983
Whole body clearance of norepinephrine. The significance of arterial sampling and of surgical stressJ Hilsted, N J Christensen, S Madsbad
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1987
Reproducibility of the glucagon testS Arnold-Larsen, S Madsbad, C Kühl
Diabetologia|December 11, 2008
The proposed terminology 'A1c-derived average glucose' is inherently imprecise and should not be adopted. Reply to Bloomgarden ZT, Inzucchi SE, Karnieli E, et alS B Haugaard, S Madsbad, J Mølvig
The Journal of Clinical Endocrinology and Metabolism|January 1, 1985
Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitusT Krarup, S Madsbad, A J Moody
Diabetologia|November 3, 2001
Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methodsL L Kjems, A Vølund, S Madsbad
Acta Chirurgica Scandinavica|February 1, 1986
Changes in T-lymphocyte subsets after elective surgeryS Madsbad, K Buschard, O Siemssen, et al.
Pageof 23